Related Experiment Video
Updated: Jul 11, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Erectile dysfunction: clinical guidelines (2).
M R Safarinejad1, S Y Hosseini
1Urology/Nephrology Research Center, Shaheed Beheshti University of Medical Sciences, Tehran, Iran. safarinrjad@unrc.ir
Erectile dysfunction affects millions of men globally. This framework guides physicians in evaluating, treating, and following up on male patients with erectile dysfunction (ED) to improve quality of life.
Area of Science:
- Urology
- Men's Health
- Sexual Medicine
Background:
- Erectile dysfunction (ED) is a prevalent condition affecting over half of men over 40.
- ED is projected to impact 322 million men worldwide by 2025.
- It is linked to aging, chronic illnesses, and modifiable risk factors.
Purpose of the Study:
- To present a comprehensive framework for the evaluation, treatment, and follow-up of male patients with erectile dysfunction.
- To guide physicians in managing erectile dysfunction.
- To address the growing prevalence and healthcare costs associated with ED.
Main Methods:
- A comprehensive literature review was conducted.
- MEDLINE database was searched for articles from 1975 to 2004 on male sexual dysfunction.
- Pertinent articles were discussed to inform the framework.
Main Results:
- Significant advancements have been made in treating erectile dysfunction (ED).
- ED can stem from various factors including vasculogenic, neurogenic, hormonal, and psychogenic causes.
- Urologists play a key role in managing ED, coordinating multidisciplinary care.
Conclusions:
- Erectile dysfunction (ED) significantly impacts men's quality of life.
- A thorough medical and psychological evaluation, involving both partners, is essential for managing ED.
- Identifying and correcting risk factors is crucial for effective treatment.
Related Concept Videos
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Male Sexual Response: Erection & Ejaculation
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Angina III: Clinical Manifestations and Assessment